Login / Signup

Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.

Fuhai MaBing-Zhi WangLiyan XueWen-Zhe KangYang LiWeikun LiHao LiuShuai MaYantao Tian
Published in: Journal of cancer research and clinical oncology (2020)
In patients with locally advanced NEC and MANEC of the stomach, NAC significantly improved OS.
Keyphrases
  • neoadjuvant chemotherapy
  • locally advanced
  • rectal cancer
  • squamous cell carcinoma
  • sentinel lymph node
  • radiation therapy
  • lymph node
  • phase ii study
  • transcription factor
  • early stage